To test whether global methylation alterations affect the clinical benefit of immunotherapy, we generated methylome and exome data for 60 samples in an anti-PD-1/PD-L1 cohort in lung cancer collected from Samsung Medical Center (SMC) (Supplementary Table 3). The gene discussed is CD274; the disease is lung carcinoma.